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A novel series of indole and benzimidazole bichalcophene diamidine derivatives were prepared to study
their antimicrobial activity against the tropical parasites causing African sleeping sickness and malaria.
The dicyanoindoles needed to synthesize the target diamidines were obtained through Stille coupling
reactions while the bis-cyanobenzimidazoles intermediates were made via condensation/cyclization
reactions of different aldehydes with 4-cyano-1,2-diaminobenzene. Different amidine synthesis meth-
odologies namely, lithium bis-trimethylsilylamide (LiN[Si(CH3)3]2) and Pinner methods were used to
prepare the diamidines. Both types (indole and benzimidazole) derivatives of the new diamidines bind
strongly with the DNA minor groove and generally show excellent in vitro antitrypanosomal activity. The
diamidino-indole derivatives also showed excellent in vitro antimalarial activity while their benzimid-
azole counterparts were generally less active. Compound 7c was highly active in vivo and cured all mice
infected with Trypanosoma brucei rhodesiense, a model that mimics the acute stage of African sleeping
sickness, at a low dose of 4  5 mg/kg i.p. and hence 7c is more potent in vivo than pentamidine.
Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Trypanosoma brucei subspecies and Plasmodium falciparum,
pathogenic single celled parasites, are the infective agents which
cause human African trypanosomiasis (sleeping sickness) and
malaria. African trypanosomes are transmitted by the blood-
sucking tsetse ﬂy and threaten about 65 million humans in the
poorest regions in the world within 36 countries. The estimated
number of patients is currenlty below 20,000 due to extensive
sleeping sickness control programmes [1]. Without an effective
treatment, African sleeping sickness is generally lethal whereas the
current drugs are still unsatisfactory [2]. Malaria is a mosquito-
borne disease which is endemic in 91 countries worldwide. Iny, Georgia State University,
of Cell Biology, Bern, 3012,
an open access article under the C2016, the WHO estimated the malaria burden to 212 million cases
and 429,000 deaths [3]. There are a number of drugs to treat ma-
laria, however drug-resistance is an ever increasing problem.
Recently, resistance has emerged also to the so far highly effective
artemisinin and artemisinin derivatives which are part of the
currently applied artemisinin based combination therapy (ACT) [4].
There is a clear need to identify new more effective and well
tolerated drugs for both of these diseases.
Aryl diamidines, DNA minor groove binders, show promise
against both parasites. Pentamidine (Fig. 1) is the only diamidine
which has shown signiﬁcant human use [5]. Pentamidine is the
treatment of choice clinically for 1st stage T. b. gambiense infections
since the 1930s and it is still effective [6]. Diminazene, is another
diamidine with high antiprotozoal activity and it is in use to treat
animal trypanosomiasis (nagana) since the 1950s [7].
We previously have reported some phenyl bichalcophenes
(compound I, Fig.1), that showed strong DNA binding and exhibited
potent antiparasitic activity [8]. In a related investigation, we
reduced the size of the molecule by removing one ﬁvemember ringC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Antiparasitic diamidines.
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benzimidazole [9] or an indole [10] moiety (compound II and III,
Fig. 1). Both approaches gave compounds that are highly active
in vitrowhile the indole containing compounds resulted in superior
in vivo activity compared to the benzimidazole containing ones.
In the present investigation, we report the synthesis of a new
class of bichalcophenes wherewe replace the 6membered aryl ring
of compound I with either an indole or a benzimidazolemoiety, this
approach also involves adding one more 5 member heterocyclic
ring to compounds of type II and III aiming for improving the
antiprotozoal effectiveness of this class of compounds.
2. Results and discussion
2.1. Chemistry
Synthesis of the indole-bichalcophene diamidine derivatives
4a-d is outlined in Scheme 1. The bis-nitriles 3a-dwere prepared by
Stille coupling [11e13] reaction between the bromo derivatives 1a-
d and 2-(trimethylstannyl)-1-(tert-butoxycarbonyl)- 1H-indole-6-
carbonitrile 2 using palladium tetrakistriphenylphosphine as a
catalyst. The bis-nitriles 3a-d on reaction with a THF solution of
lithium bis(trimethylsilyl)amide [14], followed by treatment with
ethanolic HCl yielded the hydrochloride salts of the diamidines 4a-
d.
Scheme 2, illustrates the synthetic approach for the new
benzimidazole-bichalcophene derivatives 8a-c. The aldehydes 5a-c
underwent oxidative-condensationwith 3,4-diaminobenzonitrile 6
using either sodium bisulphite in DMF or benzoquinone in ethanol
as oxidizing agents to produce the bis-nitriles 7a-c. These bis-
nitriles were converted to the corresponding diamidinesScheme 1. Reagenta and conditions: (a) Pd(PPh3),employing the Pinner methodology [15,16], where the bis-nitriles
were stirred in ethanolic HCl(gas) to produce the intermediate
imidate ester hydrochlorides that were allowed to react with
ethanolic ammonia.
2.2. Biology
Aromatic diamidines bind, in part due to their cationic nature,
strongly and reversibly with DNA. The mode of the antiprotozoal
action of the aromatic diamidines has not been fully determined,
but is thought to involve interaction with DNA dependent enzymes
or to directly inhibit DNA transcription [17]. The results for
assessment of the DNA binding afﬁnity for 4a-d and 8a-c, as well as
in vitro activity against T. b. r. STIB900 and P. f. K1 and also the in vivo
activity against T. b. r. STIB900 in mice are presented in Table 1. We
have previously reported that mesaurment of the increase in
melting temperature DTm (Tm of DNA-ligand complex e Tm of free
DNA) gives an accurate and fast method for ranking the binding
afﬁnities for aromatic diamidines [18]. The DTm values for the
diamidines/poly (dA-dT) complexes are quiet high ranging from
27 C to more than 30 C which demonstrates the strong DNA
binding afﬁnity of this class of compounds.
In general, aromatic diamidines are well known to bind in the
DNAminor groove at AT base pair sequences [19]. Circular Dichroism
(CD) has been found to be a reliable technique for detecting DNA
minor groove binding by small molecules. We observed the CD
spectra of several of the new diamidines in order to determine if
these new bichalcophenes are binding in the DNA minor groove.
Minor groove binding compounds show a large positive induced CD
signal upon binding to AT DNA sequences and lead to only minor
changes in the appearance of the DNA region of the CD spectrumdioxane; (b) i-LiN(TMS)2/THF, ii-HCl gas/EtOH.
Scheme 2. Reagenta and conditions: (a) 1,4-benzoquinone, EtOH, or Sodium bisulphite, DMF; (b) i-HCl gas/EtOH, ii-NH3 gas.
Table 1
DNA afﬁnities and antiprotozoal activity for the new diamidines.
Code DTm
(oC)a
T. b. r. (nM)b P.f. (nM)c Cytotox. (mM)d SI/T. b. r.e SI/P.ff In vivo
(cures)g
4a 28 15 2.9 16.5 1100 1000 0/4
4b >30 15 7.3 15.7 1046 2150 0/4
4c 28 4 6.8 17.6 4400 2588 4/4
4d >30 2 6.8 11.6 5800 1705 0/4
8a 29 102 91.9 41.8 409 454 NA
8b 27 64 NA 15.0 234 NA NA
8c >30 25 NA 26.2 1048 NA NA
a Thermal melting increase of poly(dA-dT)n.
b STIB900 was the strain of T. b. r. (Trypanosoma brucei rhodesiense) used.Values are the average of duplicate determinations.
c IC50 values obtained against the chloroquine resistant P. f. (Plasmodium falciparum) strain. K1. Values are the average of duplicate determinations.
d Cultured L6 rat myoblast cells was used for cytotoxicity assessment.
e Selectivity Index for T. b. r. is the ratio: IC50 (L6)/IC50 (T b.r.).
f Selectivity Index for P. f. is the ratio: IC50 (L6)/IC50 (P.f.).
g In vivo efﬁcacy determined in T. b. rhodesiense (STIB900) infected mice at 4  5 mg/kg i.p. dose.
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(dA). Poly (dT) and ﬁve of the diamidines namely (4a, 4d, 8a, 8b, 8c).
All ﬁve compounds showed very strong induced CD signals which is
evidence of a strong interaction with the DNA minor groove, clearly
supporting a minor groove binding mode for these diamidines.
The new indole bichalcophenes 4a-d are highly active against
trypanosomes (IC50 values from 2 to 15 nM) and are also very active
against malaria (IC50s from 2.9 to 7.3 nM). These narrow rangeslimit SAR evaluations. These indole analogues showed excellent
selectivity against both parasites, with selectivity indices from 1046
to 5800 against T. b. r. and from 1000 to 2588 against P. f. The
antitrypanosomal activity of the benzimidazole diamidines 8a-c
(IC50 values from 25 to 102 nM) is generally lower than that of the
indole analogues 4a-d. The antimalarial activity of the benzimid-
azole diamidine 8a is also only moderate (IC50 of 91.9 nM)
compared with its indole counterpart 4a (IC50 of 2.9 nM).
Fig. 2. Circular dichroism spectra of the titration of representative compounds, (4a, 4d, 8a, 8b, 8c) with a 20 mM Poly(dA).Poly(dT) sequence in the buffer (10 mM MES, 100 mM
NaCl, 1 mM EDTA, at pH, 7.4) at 25 C.
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bichalcophenes diamidines (4a-d) encouraged us to test them
in vivo in the rigorous T. b. r. STIB900 mouse model (Table 1) for the
acute hemolymphatic stage of the African trypanosomiasis. The
dosage applied was low with a daily intraperitoneal (i.p.) dose of
5 mg/kg compound for four consecutive days.
At this dose pentamidine cures only 1/4 infected mice [21]. The
benzimidazole bichalcophenes that were in vitro active against T. b.
r. with IC50s > 100 nM have not been tested in vivo due to inferior
in vitro activity and 8b and 8c due to termination of the project.
Compound 4cwas highly effective in vivowith 100% sterile cures in
mice infected with T. b. r. This excellent activity merits further
evaluation of 4c.3. Conclusion
The newly synthesized dicationic indole- and benzimidazole
bichalcophenes exhibited very strong DNA binding as seen from the
DTm values. Moreover, these diamidines are shown to be DNA
minor groove binders as seen from the CD spectra. Both dicationic
indole and benzimidazole derivatives showed good antimalarial
activity in vitro. Both types were also highly active against T. b. r.
whereas the dicationic indole diamidines were found to be more
active than the dicationic benzimidazole derivatives. Speciﬁcally,
the indole derivative 4cwas highly efﬁcacious in vivo curing all T. b.
r. infected mice at a low dose of 4  5 mg/kg i.p. which is more
active in vivo than the drug pentamidine that has been clinically
used to treat African sleeping sickness for more than seven decades.4. Experimental
4.1. Biology
4.1.1. Efﬁcacy and cytotoxicity studies
The in vitro viability assays were with the T. b. r. strain STIB 900
and the chloroquine resistant P. f. strain K1. The efﬁcacy studies
werewith the STIB900 acutemousemodel for T. b. r. infections [22].
Dosage was 4  5 mg/kg i.p. performed as previously described in
detail [23]. Cytotoxicity was evaluated in L6 rat myoblast cells as
previously reported in detail [24].4.1.2. Tm measurements
Thermal melting experiments were performed with a Cary 300
spectrophotometer. Cuvettes were mounted in a thermal block
where the solution temperatures were mesaured with a thermistor
in the reference cuvette. Temperatures were maintained under
computer control and increased at 0.5 C/min. The experiments
were performed in 1 cm path length quartz cuvettes in CAC 10
buffer (cacodylic acid 10mM, EDTA 1mM, NaCl 100mMwith NaOH
added to give pH ¼ 7.0). Poly (dA-dT) DNA concentrations were
determined by measuring its absorbance at 260 nm. A ratio of
0.3 mol compound per mole of DNA was used for the complex and
DNA alone was used as control [17]. DTm values were determined
from the peak of ﬁrst derivative curves (dA/dT).4.1.3. Circular dichroism (CD)
CD spectra were collected employing a Jasco J-810 spectrometer
at 25 C using different ratios of compound to DNA at 25 C in MES
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solution in a 1-cm quartz cuvette was scanned over the desired
wavelength range. Tested compounds at increasing ratios, were
titrated into the same cuvette and the complexes rescanned under
the same conditions [25].
4.2. Chemistry
All commercial reagents were used without further puriﬁcation.
All melting points were determined on a Mel-Temp 3.0 melting
point instrument, and are uncorrected. TLC analysis was carried out
on silica gel 60 F254 precoated aluminum sheets using UV light for
detection. 1H and 13C NMR spectra were recorded on a Bruker
400 MHz spectrometer using the indicated solvents. Mass spectra
were obtained from the Georgia State University Mass Spectrom-
etry Laboratory, Atlanta, GA. If the compounds are reported as salts
contain water and/or solvents, these components were detected in
HNMR spectra. Elemental analysis were performed by Atlantic
Microlab Inc., Norcross, GA. Compounds 1a-d [26] and 5a-c [27]
were previously reported.
4.2.1. General procedure for the synthesis of the dinitriles 3a-d
Tetrakistriphenylphosphine palladium (0.288 g, 0.25 mmol) was
added to a stirred solution of the 1-(tert-butoxycarbonyl)-2-(tri-
methylstannyl)-1H-indole-6-carbonitrile 2 (2.02 g, 5 mmol) and
the bromo derivatives 1a-d (5 mmol) in air free dioxane (20 mL)
under nitrogen. The reaction mixture was stirred at 90e100 C for
24 h. The reaction mixture was concentrated, the residue was
extracted with ethyl acetate (200 mL) containing 5 mL of concen-
trated ammonia to remove the residual catalyst, dried over sodium
sulfate, and evaporated. The residuewas chromatographed on silica
gel using hexanes/ethyl acetate (85/15, v/v) as solvent.
4.2.1.1. 1-(tert-Butoxycarbonyl)-2-(50-cyano-2,20-bifuran-5-yl)-1H-
indole-6-carbonitrile (3a). White solid, yield (1.19 g, 60%). mp
221e221.5 C; 1HNMR (CDCl3, 400 MHz) d 8.54(s, 1H), 7.64(d, 1H,
J¼ 8.4 Hz), 7.57(dd, 1H, J¼ 1.2 Hz, J¼ 4.0 Hz), 7.52(d, 1H, J¼ 8.4 Hz),
7.30(dd, 1H, J¼ 1.2 Hz, J¼ 4.0 Hz), 7.19(dd,1H, J¼ 1.2 Hz, J¼ 3.6 Hz),
7.16(dd, 1H, J ¼ 1.2 Hz, J ¼ 3.6 Hz), 6.78(s, 1H), 1.53(s, 9H); 13CNMR
(CDCl3, 100 MHz) d 153.2, 149.0, 136.5, 135.5, 135.1, 132.2, 131.8,
129.2, 126.3, 125.2, 125.0, 124.0, 121.4, 120.1, 119.8, 112.1, 111.6, 107.8,
106.3, 85.6, 27.7; ESI-MS: m/z calculated for C23H17N3O4: 399.4,
found: 400.3 (Mþþ1); Anal. Calcd. For C23H17N3O4: C, 69.17; H,
4.29; N, 10.52. Found: C, 69.02; H, 4.22; N, 10.33.
4.2.1.2. 1-(tert-Butoxycarbonyl)-2-(5-(5-cyanothiophen-2-yl)furan-
2-yl)-1H-indole-6-carbonitrile (3b). Yellow solid, yield (1.03 g, 50%).
mp 239e240 C; 1HNMR (CDCl3, 400MHz) d 8.58 (s, 1H), 7.67(d,1H,
J ¼ 8.0 Hz), 7.59(d, 1H, J ¼ 3.6 Hz), 7.53(dd, 1H, J ¼ 1.2, J ¼ 8.0 Hz),
7.28(d, 1H, J¼ 3.6 Hz), 6.91(s, 1H), 6.83(d, 1H, J¼ 3.6 Hz), 6.79(d, 1H,
J ¼ 3.6 Hz), 1.46(s, 9H); 13CNMR (CDCl3, 100 MHz) 148.9, 147.9,
146.8, 139.7, 138.2, 136.3, 132.0, 131.7, 126.3, 122.4, 121.7, 120.1, 119.8,
114.1, 113.1, 111.5, 109.6, 108.0, 107.8, 85.4, 27.8; ESI-MS: m/z calcu-
lated for C23H17N3O3S: 415.46, found: 416.2 (Mþþ1); Anal. Calcd.
For C23H17N3O3S: C, 66.49; H, 4.12; N,10.11. Found: C, 66.55; H, 4.04;
N, 9.99.
4.2.1.3. 1-(tert-Butoxycarbonyl)-2-(5-(5-cyanofuran-2-yl)thiophen-
2-yl)-1H-indole-6-carbonitrile (3c). Yellow solid, yield (1.01 g, 49%).
mp 221e221.5 C; 1HNMR (CDCl3, 400 MHz) d 8.56(s, 1H), 7.65(d,
1H, J ¼ 8.0 Hz), 7.53(d, 1H, J ¼ 8.0 Hz), 7.41(dd, 1H, J ¼ 0.8,
J¼ 3.6 Hz), 7.19(dd, 1H, J¼ 0.8 Hz, J¼ 4.0 Hz), 7.17(dd, 1H, J¼ 0.8 Hz,
J ¼ 4.0 Hz), 6.81(s, 1H), 6.64(dd, 1H, J ¼ 0.8 Hz, J ¼ 4.0 Hz), 1.52(s,
9H); ESI-MS: m/z calculated for C23H17N3O3S: 415.46, found: 416.2
(Mþþ1); Anal. Calcd. For C23H17N3O3S: C, 66.49; H, 4.12; N, 10.11.Found: C, 66.71; H, 4.27; N, 9.89.
4.2.1.4. 1-(tert-Butoxycarbonyl)-2-(50-cyano-2,20-bithiophen-5-yl)–
1H-indole-6-carbonitrile (3d). Yellow solid, yield (1.2 g, 56%). mp
253e255 C; 1HNMR (CDCl3, 400 MHz) d 8.55(s, 1H), 7.65(d, 1H,
J¼ 8.0 Hz), 7.58(d, 1H, J¼ 4.0 Hz), 7.53(dd, 1H, J¼ 1.2 Hz, J¼ 4.0 Hz),
7.29(d, 1H, J ¼ 3.6 Hz), 7.19(d, 1H, J ¼ 4.0 Hz), 7.15(d, 1H, J ¼ 3.6 Hz),
6.81(s, 1H), 1.53(s, 9H); ESI-MS: m/z calculated for C23H17N3O2S2:
431.53, found: 432.2 (Mþþ1); Anal. Calcd. For C23H17N3O2S2: C,
64.02; H, 3.97; N, 9.74. Found: C, 64.10; H, 3.94; N, 9.68.
4.2.2. General procedure for the synthesis of the diamidine
hydrochloride salts 4a-d
Lithium bistrimethylsilylamide 1M solution in THF (4 mL,
3.98 mmol) was added to a solution of the bis-nitriles 3a-
d (0.66 mmol) in anhydrous THF (5 mL). The reaction mixture was
stirred for 2 days at ambient temperature then cooled to zero oC
while ethanolic HCl (2 mL) was added. The mixture was allowed to
stir for 2 days, anhydrous ether was added and the solid which
formed was collected by ﬁltration. The diamidine salt was
neutralized with 1N sodium hydroxide solution followed by
ﬁltration to obtain the free base, that was washed with water and
dried. Finally, the free base was converted to the HCl salt through
stirring with ethanolic HCl for 5 days at room temperature (to
ensure removal of the Boc-group). The ethanolic mixture was
diluted with anhydrous ether, and the solid which formed was
ﬁltered and dried to give the diamidine salts.
4.2.2.1. 2-(50-Amidino-2,20-bifuran-5-yl)-1H-indole-6-amidine hy-
drochloride salt (4a). Yellow solid, yield (0.134 g, 61%), mp > 300 C;
1HNMR (DMSO-d6, 400MHz) d 12.75(s, 1H), 9.52(s, 2H), 9.33(s, 2H),
9.16(s, 2H), 9.02(s, 2H), 7.99(d,1H, J¼ 4.0 Hz), 7.97(s,1H), 7.77(d,1H,
J¼ 8.4 Hz), 7.48(d, 1H, J ¼ 8.4 Hz), 7.36(d, 1H, J ¼ 3.6 Hz), 7.32(d, 1H,
J ¼ 3.6 Hz), 7.17(d, 1H, J ¼ 4.0 Hz), 7.05(s, 1H); 13CNMR (DMSO-d6,
100 MHz) d 166.8, 153.6, 149.6, 149, 148.4, 144.3, 140.5, 136.4, 132.6,
127.3, 121.4, 121.3, 121.0, 119.5, 112.6, 110.7, 109.0, 99.9; ESI-MS: m/z
calculated for C18H15N5O2: 333.34, found: 334.2 (amidine base
Mþþ1); Anal. Calcd. For C18H15N5O2-2.0HCl-1.75H2O: C, 49.38; H,
4.71; N, 15.99. Found: C, 49.09; H, 4.92; N, 15.63.
4.2.2.2. 2-(5-(5-Amidinothiophen-2-yl)furan-2-yl)-1H-indole-6-
amidine hydrochloride salt (4b). Yellow solid, yield (0.133 g, 58%),
mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 12.55(s, 1H), 9.44(s,
2H), 9.31(s, 2H), 9.11(s, 2H), 8.96 (s, 2H), 8.14(s, 1H), 7.94(s, 1H),
7.79(d, 1H, J ¼ 8.4 Hz), 7.75(d, 1H, J ¼ 4.0 Hz), 7.48(d, 1H, J¼ 8.4 Hz),
7.35e7.28(br m, 2H), 6.99(s, 1H); 13CNMR (DMSO-d6, 100 MHz)
d 166.7,158.8,148,147.7,139.6,136.4,135.9,132.7,132.6,127.2,124.8,
121.4,121.1,119.6,122.5,112.1,111.3, 99.8; ESI-MS:m/z calculated for
C18H15N5OS: 349.41, found: 350.2 (amidine base Mþþ1); Anal.
Calcd. For C18H15N5OS-2.0HCl-2.3H2O-0.1Et2O: C, 46.90; H, 4.82; N,
14.86. Found: C, 46.94; H, 4.52; N, 14.47.
4.2.2.3. 2-(5-(5-Amidinofuran-2-yl)thiophen-2-yl)-1H-indole-6-
amidine hydrochloride salt (4c). Yellow solid, yield (0.105 g, 46%),
mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 12.60(s, 1H), 9.45(s,
2H), 9.31(s, 2H), 9.10(s, 2H), 8.98(s, 2H), 7.84e7.91(m,
2H),7.86e7.74(m, 2H), 7.75(d, 1H, J ¼ 8.4 Hz), 7.47(d, 1H, J ¼ 8.4 Hz),
7.19(d, 1H, J ¼ 3.6 Hz), 6.97(s, 1H); ESI-MS: m/z calculated for
C18H15N5OS: 349.41, found: 350.2 (amidine base Mþþ1); Anal.
Calcd. For C18H15N5OS-2.0HCl-1.8H2O-0.2Et2O: C, 48.08; H, 4.83; N,
14.91. Found: C, 47.87; H, 4.50; N, 14.52.
4.2.2.4. 2-(50-Amidino-2,20-bithiophen-5-yl)-1H-indole-6-amidine
hydrochloride salt (4d). Yellow solid, yield (0.123 g, 51%),
mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 12.60(s, 1H), 9.44(s,
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7.92(s, 1H), 7.81(d, 1H, J ¼ 3.6 Hz), 7.74(d, 1H, J ¼ 8.0 Hz),
7.67e7.63(m, 2H), 7.47(d, 1H, J ¼ 8.0 Hz), 6.97(s, 1H); 13CNMR
(DMSO-d6, 100 MHz) d 166.8, 158.7, 143.8, 136.6, 136.1, 135.8, 135.0,
134.6, 132.8, 128.3, 127.3, 127.2, 125.7, 121.3, 120.8, 119.6, 112.4,
100.7; ESI-MS: m/z calculated for C18H15N5S2: 365.48, found: 366.2
(amidine base Mþþ1); Anal. Calcd. For C18H15N5S2-2.0HCl-1.6H2O:
C, 46.28; H, 4.35; N, 14.97. Found: C, 46.60; H, 4.18; N, 14.68.
4.2.3. General procedure for the synthesis of the dinitriles 7a-c
4.2.3.1. First method. 1,4-Benzoquinone (1.82 g, 16.9 mmol) was
added to a suspension of 3,4-diaminobenzonitrile (1.5 g,
11.25 mmol) and the aldehydes 5a-c (12.3 mmol) in ethanol
(60 mL). The mixture was reﬂuxed under nitrogen for 12 h. The
solvent was removed under reduced pressure. Puriﬁcation was
performed using chromatography on silica gel, and hexanes/ethyl
acetate (50/50, v/v) as solvent.
4.2.3.2. Second method. Sodium bisulphite (4.3 g, 22.5 mmol) was
added to a suspension of 3,4-diaminobenzonitrile (1.5 g,
11.25 mmol) and the aldehydes 5a-c (12.3 mmol) in dime-
thylformamide (20 mL). The reaction mixture was reﬂuxed for 8 h
under nitrogen. The reaction mixture was poured into water,
ﬁltered and the solid was dried. Puriﬁcation was done using chro-
matography on silica gel, and hexanes/ethyl acetate (50/50, v/v) as
solvent.
4.2.3.3. 2-(50-Cyano-2,20-bifuran-5-yl)-1H-benzimidazole-5(6)-car-
bonitrile (7a). White solid, yield (1.85 g, 55%). mp 280e282 C;
1HNMR (DMSO-d6, DMSO-d6, 400 MHz) d 13.7(s, 1H), 8.2(s, 1H),
7.82(d, 1H, J ¼ 3.6 Hz), 7.72e7.64(m, 2H), 7.49(brs, 1H), 7.32(d, 1H,
J ¼ 3.6 Hz), 7.19(d, 1H, J ¼ 3.6 Hz); ESI-MS: m/z calculated for
C17H8N4O2: 300.27, found: 301.1 (Mþþ1); Anal. Calcd. For
C17H8N4O2: C, 68.00; H, 2.69; N, 18.66. Found: C, 68.02; H, 2.74; N,
18.49.
4.2.3.4. 2-(5-(5-Cyanothiophen-2-yl)furan-2-yl)-1H-benzimidazole-
5(6)-carbonitrile (7b). White solid, yield (2.16 g, 61%). mp
291e293 C; 1HNMR (DMSO-d6, 400 MHz) d 13.7(s, 1H), 8.17(brs,
1H), 8.05(d, 1H, J¼ 4 Hz), 7.76 (brs, 1H), 7.74(d, 1H, J ¼ 4 Hz), 7.64(d,
1H, J ¼ 8 Hz), 7.48(d, 1H, J ¼ 3.6 Hz), 7.39(d, 1H, J ¼ 3.6 Hz); 13CNMR
(DMSO-d6, 100 MHz) d 149.1, 146.0, 145.9, 145.4, 140.7, 139.1, 139.0,
126.7, 126.0, 125.3, 120.4, 116.1, 115.2, 114.8, 112.1, 107.6, 104.9; ESI-
MS: m/z calculated for C17H8N4OS: 316.33, found: 317.1 (Mþþ1);
Anal. Calcd. For C17H8N4OS: C, 64.55; H, 2.55; N, 17.71. Found: C,
64.32; H, 2.57; N, 17.63.
4.2.3.5. 2-(50-Cyano-2,20-bithiophen-5-yl)-1H-benzimidazole-5(6)-
carbonitrile (7c). Yellwish white solid, yield (2.57 g, 69%).
mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 13.8(s, 1H), 8.14(brs,
1H), 8 (d, 1H, J ¼ 3.6 Hz), 7.93 (brs, 1H), 7.74(brs, 1H), 7.71(d, 1H,
J ¼ 3.2 Hz), 7.64(d, 1H, J ¼ 3.2 Hz), 7.62(s, 1H); ESI-MS: m/z calcu-
lated for C17H8N4S2: 332.4, found: 333 (Mþþ1); Anal. Calcd. For
C17H8N4S2: C, 61.43; H, 2.43; N, 16.86. Found: C, 61.22; H, 2.45; N,
16.85.
4.2.4. General method for the preparation of the diamidine
hydrochloride salts 8a-c
The bis-nitriles 7a-c (2.1 mmol) were suspended in saturated
ethanolic-HCl(gas) and stirred at ambient temperature for 1 week,
with complete isolation from air. Anhydrous ether was added and
the crystals which formed were ﬁltered, dried under vacuum for
30 min and then suspended in anhydrous ethanol. Ammonia gas
was bubbled into the solution for 1 h while keeping the reaction
temperature at 0e5 C and the resulting solution was stirred atroom temperature for 4 days. Anhydrous ether was added and the
precipitated crystals (HCl salt) were ﬁltered. The ﬁnal compounds
were puriﬁed ﬁrst by neutralization with 1N sodium hydroxide
solution followed by ﬁltration of the formed free base which was
washed with water and dried. The free base was stirred with
ethanolic-HCl(gas) for 2 days, diluted with anhydrous ether, and
the solid which formed was ﬁltered and dried to give the diamidine
hydrochloride salt.
4.2.4.1. 2-(50-Amidino-2,20-bifuran-5-yl)-1H-benzimidazole-5(6)-
amidine hydrochloride salt (8a). Yellow solid, yield (0.45 g, 42%),
mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 9.8(s, 2H), 9.76(s, 2H),
9.74(s, 2H), 9.6(s, 2H), 8.19(d, 1H, J ¼ 4 Hz), 8.02(d, 1H, J ¼ 4 Hz),
7.84(d, 1H, J ¼ 8.4 Hz), 7.76(d, 1H, J ¼ 8.4 Hz), 7.71(dd, 1H, J ¼ 8 Hz,
4 Hz), 7.32e7.27(m, 1H), 7.21(brs, 1H); ESI-MS: m/z calculated for
C17H14N6O2: 334.33, found: 335.2 (amidine base Mþþ1); Anal.
Calcd. For C17H14N6O2-2.0HCl-2.75H2O-0.75Et2O: C, 46.88; H, 5.70;
N, 16.40. Found: C, 46.59; H, 5.95; N, 16.16.
4.2.4.2. 2-(5-(5-Amidinothiophen-2-yl)furan-2-yl)-1H-benzimid-
azole-5(6)-amidine hydrochloride salt (8b). Yellow solid, yield
(0.42 g, 39%), mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 9.5(s,
2H), 9.4(s, 2H), 9.18(s, 2H), 9.08(s, 2H), 8.23e8.15(m, 2H),
7.83e7.81(m, 2H), 7.73(d, 1H, J ¼ 8.8 Hz), 7.63(brs, 1H), 7.39(brs,
1H); ESI-MS: m/z calculated for C17H14N6OS: 350.39, found: 351
(amidine base Mþþ1); Anal. Calcd. For C17H14N6OS-2.0HCl-
2.75H2O-0.65Et2O: C, 45.18; H, 5.41; N, 16.12. Found: C, 45.22; H,
5.70; N, 15.95.
4.2.4.3. 2-(50-Amidino-2,20-bithiophen-5-yl)-1H-benzimidazole-
5(6)-amidine hydrochloride salt (8c). Yellow solid, yield (0.37 g,
37%), mp > 300 C; 1HNMR (DMSO-d6, 400 MHz) d 9.49(s, 2H),
9.39(s, 2H), 9.27(s, 2H), 9.18(s, 2H), 8.15e8.13(m, 3H), 7.79e7.70(m,
4H); ESI-MS: m/z calculated for C17H14N6S2: 366.46, found: 367
(amidine base Mþþ1); Anal. Calcd. For C17H14N6S2-3.0HCl-0.5H2O:
C, 42.11; H, 3.74; N, 17.33. Found: C, 41.98; H, 4.02; N, 17.03.
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